CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients
✍ Scribed by Xiaorong Lin; Nancy H. Gudgeon; Edwin P. Hui; Hui Jia; Xue Qun; Graham S. Taylor; Martin C. N. M. Barnardo; C. Kit Lin; Alan B. Rickinson; Anthony T. C. Chan
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 585 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Interleukin-10 (IL-10) is an inhibitory cytokine produced by various cell types. It exhibits strong sequence homology to BCRF-1 (viral IL-10, vIL-10), an open reading frame in the Epstein-Barr-virus (EBV) genome. Using in situ hybridization (ISH), polymerase chain reaction (PCR) and immunohistochemi
## Abstract Epstein Barr virus (EBV) causes lymphomas in immune competent and, at increased frequencies, in immune compromised patients. In the presence of an intact immune system, EBV‐associated lymphomas express in most cases only 3 or fewer EBV antigens at the protein level, always including the
## Abstract Immune responses to three Epstein–Barr virus (EBV) lytic proteins, DNase, thymidine kinase (TK), and BMRF‐1 gene products (50/52 kDa diffused early antigen, EA‐D complex) were determined in EBV‐infected control individuals and patients with nasopharyngeal carcinoma (NPC). Immunofluoresc
## Abstract Antibody‐dependent cellular cytotoxicity (ADCC) was performed on serum samples from African patients with nasopharyngeal carcinoma (NPC) to determine whether antibody titers determined by this assay might be of prognostic value in this disease. The serum donors were divided into two gro